These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31882749)

  • 1. c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth.
    Lyle C; Richards S; Yasuda K; Napoleon MA; Walker J; Arinze N; Belghasem M; Vellard I; Yin W; Ravid JD; Zavaro E; Amraei R; Francis J; Phatak U; Rifkin IR; Rahimi N; Chitalia VC
    Sci Rep; 2019 Dec; 9(1):20257. PubMed ID: 31882749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia.
    Checquolo S; Palermo R; Cialfi S; Ferrara G; Oliviero C; Talora C; Bellavia D; Giovenco A; Grazioli P; Frati L; Gulino A; Screpanti I
    Oncogene; 2010 Mar; 29(10):1463-74. PubMed ID: 19966856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
    Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
    Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 6. PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.
    Chocarro L; Blanco E; Fernandez-Rubio L; Garnica M; Zuazo M; Garcia MJ; Bocanegra A; Echaide M; Johnston C; Edwards CJ; Legg J; Pierce AJ; Arasanz H; Fernandez-Hinojal G; Vera R; Ausin K; Santamaria E; Fernandez-Irigoyen J; Kochan G; Escors D
    EMBO Mol Med; 2024 Aug; 16(8):1791-1816. PubMed ID: 39030301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
    Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
    J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-β production and cellular antiviral response.
    Zhao X; Zhu H; Yu J; Li H; Ge J; Chen W
    Cell Signal; 2016 Nov; 28(11):1683-93. PubMed ID: 27503123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.
    Kumaradevan S; Lee SY; Richards S; Lyle C; Zhao Q; Tapan U; Jiangliu Y; Ghumman S; Walker J; Belghasem M; Arinze N; Kuhnen A; Weinberg J; Francis J; Hartshorn K; Kolachalama VB; Cifuentes D; Rahimi N; Chitalia VC
    Am J Pathol; 2018 Aug; 188(8):1921-1933. PubMed ID: 30029779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
    Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
    Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells.
    Qu JL; Qu XJ; Qu JL; Qu XJ; Zhao MF; Teng YE; Zhang Y; Hou KZ; Jiang YH; Yang XH; Liu YP
    Acta Oncol; 2009; 48(8):1173-80. PubMed ID: 19863226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
    Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
    J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
    Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
    J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.
    Chitalia V; Shivanna S; Martorell J; Meyer R; Edelman E; Rahimi N
    J Biol Chem; 2013 Aug; 288(32):23505-17. PubMed ID: 23744067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth.
    Yan Z; Cheng M; Hu G; Wang Y; Zeng S; Huang A; Xu L; Liu Y; Shi C; Deng L; Lu Q; Rao H; Lu H; Chen YG; Luo S
    Cell Death Dis; 2021 Feb; 12(2):199. PubMed ID: 33608498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
    Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
    J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
    Liu Q; Zhou H; Langdon WY; Zhang J
    Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
    Tang J; Tu S; Lin G; Guo H; Yan C; Liu Q; Huang L; Tang N; Xiao Y; Pope RM; Rajaram MVS; Amer AO; Ahmer BM; Gunn JS; Wozniak DJ; Tao L; Coppola V; Zhang L; Langdon WY; Torrelles JB; Lipkowitz S; Zhang J
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31999304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.